EBS icon

Emergent Biosolutions
EBS

Overview Fund Activity

214 hedge funds and large institutions have $1.22B invested in Emergent Biosolutions in 2016 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 84 increasing their positions, 76 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
214
Holders Change
+9
Holders Change %
+4.39%
% of All Funds
5.71%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.05%
New
33
Increased
84
Reduced
76
Closed
23
Calls
$2.64M
Puts
$6.25M
Net Calls
-$3.61M
Net Calls Change
-$2.92M

Top Buyers

1
Acadian Asset Management
1
Acadian Asset Management
Massachusetts
$57.7M
2
Ameriprise
2
Ameriprise
Minnesota
$22.3M
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$116M
4
TA
4
Teachers Advisors
New York
$9.71M
5
State Street
5
State Street
Massachusetts
$40M

Top Sellers

1
BC
1
Broadfin Capital
New York
$0
2
Bank of New York Mellon
2
Bank of New York Mellon
New York
$49.2M
3
NI
3
Numeric Investors
Massachusetts
$0
4
TC
4
TFS Capital
Pennsylvania
$970K
5
FMA
5
Fiduciary Management Associates
Illinois
$18.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
DIA
226
Denver Investment Advisors
Colorado
– -$280K -6,996 Closed
Stifel Financial
227
Stifel Financial
Missouri
– -$248K -6,189 Closed
Jane Street
228
Jane Street
New York
– -$231K -5,770 Closed
PA
229
Profund Advisors
Maryland
– -$222K -5,548 Closed
ProShare Advisors
230
ProShare Advisors
Maryland
– -$207K -5,173 Closed
IA
231
IFP Advisors
Florida
– -$21K -519 Closed
TRCT
232
Tower Research Capital (TRC)
New York
– -$12K -300 Closed
Simplex Trading
233
Simplex Trading
Illinois
– -$4K -109 Closed
KCPG
234
Kavar Capital Partners Group
Kansas
– -$1K -25 Closed
6 7 8 9
10